Timothy Mayleben, President & CEO, Director at Esperion, holds 122.70K shares in Esperion (Ticker: ESPR), holds ― shares in Landos Biopharma (Ticker: LABP), holds 22.07K shares in Marinus (Ticker: MRNS). Most recently, Timothy Mayleben Bought ― shares of Esperion on Dec 31, 2020 for an estimated value of 22.36K.